Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000129.xml
Kardiologie up2date 2021; 17(04): 307-310
DOI: 10.1055/a-1496-6466
DOI: 10.1055/a-1496-6466
SOP
SOPAntithrombotische Therapie bei Patienten mit Koronarintervention und Indikation zur Antikoagulation
Die antithrombotische Therapie in der Kardiologie hat in den letzten Jahren eine bemerkenswerte Entwicklung genommen. Neue Medikamente wurden entwickelt und bekannte und neue klinische Indikationen sind in großen Studien sorgfältig überprüft worden. Hier wird die Entscheidungsfindung zur kombinierten, antithrombotischen Therapie bei Patienten mit einer Indikation zur Gerinnungshemmung und gleichzeitiger Koronarintervention dargestellt.
Publication History
Article published online:
14 December 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Hindricks G, Potpara T, Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42 (05) 373-498 DOI: 10.1093/eurheartj/ehaa612. (PMID: 32860505)
- 2 Ruff CT, Giugliano RP, Braunwald E. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955-962 DOI: 10.1016/S0140-6736(13)62343-0. (PMID: 24315724)
- 3 Neumann FJ, Sousa-Uva M, Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87-165 DOI: 10.1093/eurheartj/ehy394. (PMID: 30165437)
- 4 Knuuti J, Wijns W, Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-477 DOI: 10.1093/eurheartj/ehz425. (PMID: 31504439)
- 5 Valgimigli M, Bueno H, Byrne RA. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213-260 DOI: 10.1093/eurheartj/ehx419. (PMID: 28886622)
- 6 van Rein N, Heide-Jorgensen U, Lijfering WM. et al. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy. Circulation 2019; 139: 775-786 DOI: 10.1161/CIRCULATIONAHA.118.036248. (PMID: 30586754)
- 7 Collet JP, Thiele H, Barbato E. et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021; 42 (14) 1289-1367 DOI: 10.1093/eurheartj/ehaa575. (PMID: 32860058)